A week after announcing it was negotiating a non-binding letter of intent regarding a possible merger with Anteris Technology, Medicus Sciences Acquisition in an 8-K filing disclosed that those discussions have ceased.
Anteris is an Australia-based medical tech company focused on structural heart components, including heart valves.
Medicus raised $92 million in an IPO a year ago. The SPAC has a Feb. 18, 2023 deadline to complete a deal. Read more.
